ABBOTT LABORATORIES Available-for-sale Securities, Gross Unrealized Loss
ABBOTT LABORATORIES (ABT) reported Available-for-sale Securities, Gross Unrealized Loss of -$1.00 million for the 12-month period ending 2010-12-31, per its 10-K filed 2011-02-18.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss · last filed 2011-02-18
- ABBOTT LABORATORIES available-for-sale securities, gross unrealized loss for fiscal 2010 was -$1.00M.
- ABBOTT LABORATORIES available-for-sale securities, gross unrealized loss for fiscal 2009 was -$3.00M.
- ABBOTT LABORATORIES available-for-sale securities, gross unrealized loss for fiscal 2008 was -$23.00M.
| Period end | Available-for-sale Securities, Gross Unrealized Loss 12 month |
|---|---|
| 2010-12-31 | -$1.00M 10-K · filed 2011-02-18 |
| 2009-12-31 | -$3.00M 10-K · filed 2011-02-18 |
| 2008-12-31 | -$23.00M 10-K · filed 2011-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |